You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 25, 2024

CLINICAL TRIALS PROFILE FOR EPLERENONE

✉ Email this page to a colleague

« Back to Dashboard

All Clinical Trials for EPLERENONE

Subscribe to access the full database, or Sign Up
Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT00082589 ↗	The Purpose of This Study is to Determine if Eplerenone is Effective in Treatment of Mild to Moderate Heart Failure	Completed	Pfizer	Phase 4	2004-04-01	The purpose of this study is to determine if eplerenone is effective in the treatment of mild to moderate heart failure
NCT00082589 ↗	The Purpose of This Study is to Determine if Eplerenone is Effective in Treatment of Mild to Moderate Heart Failure	Completed	Pfizer's Upjohn has merged with Mylan to form Viatris Inc.	Phase 4	2004-04-01	The purpose of this study is to determine if eplerenone is effective in the treatment of mild to moderate heart failure
NCT00094302 ↗	Aldosterone Antagonist Therapy for Adults With Heart Failure and Preserved Systolic Function	Completed	National Heart, Lung, and Blood Institute (NHLBI)	Phase 3	2006-08-01	The purpose of this study is to evaluate the effectiveness of aldosterone antagonist therapy in reducing cardiovascular mortality, aborted cardiac arrest, and heart failure hospitalization in patients who have heart failure with preserved systolic function.
>Trial ID	>Title	>Status	>Sponsor	>Phase	>Start Date	>Summary

Clinical Trial Conditions for EPLERENONE

Condition Name

Chart
Table

Condition Name for EPLERENONE
Intervention	Trials
Hypertension	27
Heart Failure	11
Central Serous Chorioretinopathy	4
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Condition MeSH

Chart
Table

Condition MeSH for EPLERENONE
Intervention	Trials
Hypertension	29
Heart Failure	24
Renal Insufficiency, Chronic	9
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Locations for EPLERENONE

Trials by Country

Map
Table

Trials by Country for EPLERENONE
Location	Trials
United States	208
Japan	46
Canada	30
United Kingdom	20
Germany	17
This preview shows a limited data set Subscribe for full access, or try a Trial

Trials by US State

Map
Table

Trials by US State for EPLERENONE
Location	Trials
Massachusetts	15
Tennessee	13
Ohio	11
California	11
Florida	10
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Progress for EPLERENONE

Clinical Trial Phase

Chart
Table

Clinical Trial Phase for EPLERENONE
Clinical Trial Phase	Trials
Phase 4	44
Phase 3	19
Phase 2/Phase 3	4
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Status

Chart
Table

Clinical Trial Status for EPLERENONE
Clinical Trial Phase	Trials
Completed	66
Unknown status	15
Terminated	14
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Sponsors for EPLERENONE

Sponsor Name

Chart
Table

Sponsor Name for EPLERENONE
Sponsor	Trials
Pfizer	17
Brigham and Women's Hospital	13
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.	8
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Sponsor Type

Chart
Table

Sponsor Type for EPLERENONE
Sponsor	Trials
Other	169
Industry	53
NIH	9
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.